The efficacy of switching basal–bolus insulin therapy to basal insulin-supported oral therapy with a glinide and an α-glucosidase inhibitor in patients with type 2 diabetes depends on insulin secretory capacity, but not on blood glucose profiles and insulin dosages prior to the switching
Author:
Funder
Kissei
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://link.springer.com/content/pdf/10.1007/s13340-023-00651-z.pdf
Reference40 articles.
1. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan B, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109109. https://doi.org/10.1016/j.diabres.2021.109119.
2. Takeshita Y, Takamura T, Kita Y, Takazakura A, Kato K, Isobe Y, et al. Sitagliptin versus mitiglinide switched from mealtime dosing of a rapid-acting insulin analog in patients with type 2 diabetes: a randomized, parallel-group study. BMJ Open Diabetes Res Care. 2015. https://doi.org/10.1136/bmjdrc-2015-000122.
3. Tsukube S, Ikeda Y, Kadowaki T, Odawara M. Improved treatment satisfaction and self-reported health status after introduction of basal-supported oral therapy using insulin glargine in patients with type 2 diabetes: sub-analysis of ALOHA2 study. Diabetes Ther. 2015. https://doi.org/10.1007/s13300-015-0111-5.
4. Li H. Revisiting the strategies for the pharmacological management of type 2 diabetes—from glycemic control, organ protection, safety to weight reduction. J Diabetes Investig. 2022;13(1):3–5. https://doi.org/10.1111/jdi.13726.
5. Danne T, Bluhmki T, Seufert J, Kaltheuner M, Rathmann W, Beyersmann J, et al. Treatment intensification using long-acting insulin -predictors of future basal insulin supported oral therapy in the DIVE registry. BMC Endocr Disord. 2015;15:54. https://doi.org/10.1186/s12902-015-0051-0.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3